Skip to content
Heavy Metal Index

Heavy metals in Research Chemicals, Peptides & SARMs

This page reports published measurements and their limitations. Compare values only when the product form, measurement basis, and metal species match.

4 related source records are associated with this category. This is a coverage count, not a measure of scientific confidence. References identify works cited in the text.

Literature scope

Janvier et al. 2018 is listed on this page. The direct answer also uses the European Medicines Agency 2025 guideline and the University of Calgary 2026 bulletin, which are filed source pages. Some sections below are still empty because they have not been filled.

Direct answer

For the question of whether research peptides get heavy-metal tested, this category page does not name vendors. Janvier et al. 2018 acquired 27 unregulated polypeptide preparations sold as research chemicals, measured elemental impurities by ICP-MS against ICH Q3D parenteral limits, and reported inorganic arsenic at 1660 to 12,890 ppb in 6 of 27 preparations against a cited arsenic limit of 1500 ppb, with one of 27 above a cited lead limit of 500 ppb and no printed lead concentration for that sample, while mercury and nickel had insufficient material to assess (Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market, DOI 10.1016/j.talanta.2018.06.023). The European Medicines Agency 2025 guideline places authorized synthetic peptide medicines under ICH Q3D and prints no occurrence concentration (Guideline on the Development and Manufacture of Synthetic Peptides, no DOI), and the University of Calgary 2026 bulletin prints no original measurement (Clinical Pharmacology & Toxicology Pearl of the Week — Unauthorized Injectable Peptides, no DOI).

References

Works cited in this page’s text, in first-appearance order. This is not the full corpus for this page; it is only what the prose above draws on. The complete set of sources is listed under Sources below. Each title links to its source record.

  1. Lead Astray? The Hidden Contaminants in Australian Anabolic–Androgenic Steroid Market and Their Potential Health ImpactCraven A, Ferris J, Nielsen S, and Piatkowski T · Drug and Alcohol Review · 2025 · doi.org/10.1111/dar.70007Peer-reviewed

Sources

Sources catalogued for this page. The last column says how each source is used here.

#CitationYearTypeUsed on this page for
1Craven et al. 2025. Lead Astray? The Hidden Contaminants in Australian Anabolic–Androgenic Steroid Market and Their Potential Health Impact, Drug and Alcohol Review2025Peer-reviewedAU Pb, Cd, tAs, Al, Cr, Ni occurrence in 28 illicit anabolic–androgenic steroid (AAS) products anonymously donated by people who use AAS in Australia (reportedly purchased 2022–2024):… (n=28)
2Janvier et al. 2018. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market, Talanta2018Peer-reviewedBE iAs, tAs, Pb, Cd occurrence in 27 falsified/unregulated polypeptide drug preparations acquired as ‘research chemicals’ from three suspected illegal internet pharmacies and delivered to… (n=27)
3University of Calgary Clinical 2026. Clinical Pharmacology & Toxicology Pearl of the Week — Unauthorized Injectable Peptides, CPT Pearl of the Week (Alberta Health Services / University of Calgary Cumming School of Medicine)2026Government reportContribution to this topic remains under review; see the source record for its reported scope.
4EMA 2025. Guideline on the Development and Manufacture of Synthetic Peptides, European Medicines Agency2025Regulatory guidelineContribution to this topic remains under review; see the source record for its reported scope.

Update history

The five most recent substantive edits to this page, classified major (evidence or structure moved), correction (a published value or statement was wrong and has been fixed), or minor (narrative rewritten without changing the underlying evidence). Each description is derived from what the edit did to this page; the linked commit is the authoritative record, routine regeneration passes are excluded, and the full version history lives in git. When DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.

CommitDateChangeDescription
b01ec52c32026-08-04major1 source added; narrative text revised
3a67e13072026-08-02minorNarrative text revised
33273ad692026-08-02major1 source added; narrative text revised
90a2f9a382026-07-30major2 sections added and 1 removed; narrative text revised
bff8abb722026-07-27correction2 sections added and 1 removed; narrative text revised